Therakine have a legit, sustaining delivery method here that could or is already bringing in millions of revenue. Especially if they tie it to cannabis and could already have the products developed for the medical cannabis industry. I think they're keeping that hush at the moment as their website is down.
Remember at only a 50mm marketcap puts this at $.04 but I think we're headed higher.
These are some of the companies our IR company represents. MariMed Inc $511 Million Marijuana Company of America $66 Million SQL Technologies Corp $160 Million Kaya Holdings $20 Million
Mr. Yakatan: In simple forms, we figured out a way to take an existing drug and extend its life, whether it is hydrophobic or hydrophilic. We can then place, for example, a six months supply of the drug directly into the body and have it released exactly when it needs to be. What is unique is that we use physics, instead of modifying the drug chemically: we mechanically form biopolymers or biopolymer derivatives using only already approved additives. Then we modify those carefully under controlled conditions. Then we create a number of cycles of pressing and kneading that transform the mixture of ingredients into a polymer elastic body of high stability.
Here is info about Therakine licencing their delivery method for Naltrexone to BicxCorp (52 week high of .$28) with an estimsted demand of $185 million in 2016.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.